Magnetic resonance imaging and spectroscopic imaging: Improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples